Denali Therapeutics DNLI
NASDAQ DNLI
$20.79 -0.02 (-0.10%)
As of: Sep 30, 2026 · 9:37 AM EDT

Denali Therapeutics (DNLI) Total Non-Current Liabilities (2017 - 2025)

Updated

Denali Therapeutics' Total Non-Current Liabilities came in at $125.39 million for Q3 2025, down 4.7% from $131.57 million a year earlier and down 2.6% from the prior quarter.

Analysis

Denali Therapeutics (DNLI) Total Non-Current Liabilities (2017 - 2025) Analysis & Trends

At the end of FY2024, Denali Therapeutics' Total Non-Current Liabilities was $144.5 million, up 17.5% from FY2023.

  • Total Non-Current Liabilities carries a five-year compound annual growth rate of -1.8% (FY2019 to FY2024).
  • Going back by year, Total Non-Current Liabilities was $122.96 million in FY2023 (-70.5%), $417.43 million in FY2022 (-5.4%), $441.49 million in FY2021 (-2.6%) and $453.05 million in FY2020 (+186.8%).
  • The Q3 2025 figure represents the lowest quarterly Total Non-Current Liabilities since Q4 2023.
  • Year-over-year, Total Non-Current Liabilities increased in two of the last four quarters, with an average decline of 11.6%.
  • The fastest year-over-year change in Total Non-Current Liabilities over five years came in Q2 2021 (growth of 201.4%), and the weakest in Q3 2023 (a decline of 71.6%).
  • Business Quant data shows DNLI's Total Non-Current Liabilities at $128.74 million (Q2 2025), $131.92 million (Q1 2025) and $144.5 million (Q4 2024) in the three quarters before Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 105.99 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 106.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -967.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 5.92 Bn
10 Denali Therapeutics 3.35 Bn 3.35 Bn 3.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 125.39 Mn
Jun 30, 2025 128.74 Mn
Mar 31, 2025 131.92 Mn
Dec 31, 2024 144.50 Mn
Sep 30, 2024 131.57 Mn
Dec 31, 2023 122.96 Mn
Sep 30, 2023 118.07 Mn
Jun 30, 2023 118.53 Mn
Mar 31, 2023 442.26 Mn
Dec 31, 2022 417.43 Mn
Sep 30, 2022 415.92 Mn
Jun 30, 2022 407.64 Mn
Mar 31, 2022 402.55 Mn
Dec 31, 2021 441.49 Mn
Sep 30, 2021 436.99 Mn
Jun 30, 2021 436.41 Mn
Mar 31, 2021 441.80 Mn
Dec 31, 2020 453.05 Mn
Sep 30, 2020 187.38 Mn
Jun 30, 2020 144.79 Mn
API Access

Denali Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=DNLI&period=max&api_key=YOUR_API_KEY